Form 4 holding
Chief Legal Officer
Immunovant, Inc.
- Security class
- Common Stock
- Shares / value
- 319,228
- Estimated value
- $8,124,353
- Report date
- 20 Nov 2024
- Price
- $25.45
- Ownership
- Direct
Mark S. Levine - Chief Legal Officer at Immunovant, Inc.
Issuer-level insider activity
- Role
- Chief Legal Officer
- Issuer ticker
- IMVT on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Mark S. Levine since 25 Aug 2025
Reported holdings for Mark S. Levine in Immunovant, Inc.
Form 4 holding
Chief Legal Officer
Immunovant, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 68,723
- Estimated value
- Report date
- 02 Apr 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Mark S. Levine in Immunovant, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.